Latest News
Analysts monitoring heart implant sales as Medtronic reports second-quarter earns
Chicago Tribune | 11 hours 18 minutes ago
WASHINGTON (AP) ? Medtronic, the world's largest medical device maker, reports earnings for the second fiscal quarter of 2010 on Tuesday. The following is a summary of key developments and analyst opinion for the last period.... (more)
Analyst says stocks will benefit from reform clarity, and from lower medical costs after 2010 -- South Florida Sun-Sentinel.com
Sun-Sentinel (Fort Lauderdale, Fla.) | 11 hours 19 minutes ago
NEW YORK (AP) — An analyst for JPMorgan upgraded shares of WellPoint Inc. and Cigna Corp. Monday, saying the stocks should trade higher as the details of a federal health care reform bill come into focus.... (more)
Cigna, WellPoint upgraded on costs, reform details
San Francisco Chronicle | 11 hours 19 minutes ago
You must be signed in to add a comment. Sign In | Register... (more)
Bristol-Myers extends partnership with Asterand
Miami Herald, The | 11 hours 54 minutes ago
NEW YORK -- Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.... (more)
Former ZymoGenetics CEO named to Immune Design posts
American City Business Journals | 11 hours 55 minutes ago
Bruce Carter, who headed Seattle biotech ZymoGenetics Inc.... (more)
Next-generation flu vaccine plant to open in U.S.
Reuters | 11 hours 56 minutes ago
WASHINGTON (Reuters) - Novartis will officially open the first next-generation flu vaccine plant in the United States on Tuesday, but it will be years before it makes its first vaccine.... (more)
Texas court tosses state Vioxx suit against Merck
Reuters | 11 hours 56 minutes ago
NEW YORK (Reuters) - A Texas court has dismissed a lawsuit brought by the state against drugmaker Merck & Co that sought a refund for money spent on the withdrawn Vioxx pain treatment, the company said on Monday.... (more)
Raptor's genetic disorder drug meets study goals
Miami Herald, The | 11 hours 57 minutes ago
NOVATO, Calif. -- Raptor Pharmaceutical Corp. said Monday its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.... (more)
Pfizer, Immunovaccine in animal vaccine deal
Miami Herald, The | 11 hours 58 minutes ago
NEW YORK -- Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.... (more)
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
TheStreet.com | 11 hours 59 minutes ago
VIENNA, Va. (TheStreet) -- Cel-Sci(CVM Quote) founder and chairman Maximilian de Clara sold nearly one quarter of his common stock holdings in the company, according to a late Friday filing with the Securities and Exchange Commission.... (more)
Pfizer, Immunovaccine will collaborate on cattle vaccines; terms of partnership not disclosed
Sun (Baltimore), The | 11 hours 59 minutes ago
Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.... (more)
292 Stories |
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
Tales of the Grim Reaper from Montreal
Health business blog
Are Your Kids Active Enough?
Diet-Blog
Public Anxiety Meets The Democratic Effort to Get Health Care Done at All Costs
Health Care Blog, The
Grasping the Third Rail
Stayin' Alive
Companies in the news
- Abraxis Bioscience Inc
- Biogen IDEC Inc.
- Biomarin Pharmaceutical
- Boston Scientific Corp.
- Dendreon Corp
- GlaxoSmithKline plc
- Humana Inc
- IVAX
- Johnson & Johnson
- Medtronic Inc
- Merck & Co.
- Nabi Biopharmaceuticals
- Omnicare Inc
- Progenics Pharmaceutical
- Sciele Pharma Inc
